Comparing dual oral agents plus insulin vs. Triple oral agents in uncontrolled type II diabetes: A pilot study. Gul N, Rehman IU, Shah Y, Ali AM, et al. PLoS One 2024;19:e0311435.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gul N, Rehman IU, Shah Y, Ali AM, et al. Comparing dual oral agents plus insulin vs. Triple oral agents in uncontrolled type II diabetes: A pilot study. PLoS One 2024;19:e0311435.
PMID: 39570934